Researchers at the University of Arizona Health Sciences have identified compounds from the Cannabis sativa plant that may offer a new way to treat fibromyalgia and post-surgical pain. The findings, published in Pharmacological Reports, add to growing evidence that certain cannabis-derived molecules could help relieve chronic pain without causing the psychoactive effects associated with THC.
The study builds on earlier work from the lab of John Streicher, PhD, a member of the Comprehensive Center for Pain & Addiction, which found that terpenes could reduce pain in models of inflammation and chemotherapy-related nerve damage.
